Molecular mechanisms of glycogen particle assembly in Escherichia coli.

Escherichia coli Glycogen debranching enzyme Glycogen phosphorylase Glycogen α particle Structural fragility

Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
01 Jan 2023
Historique:
received: 14 09 2022
revised: 02 10 2022
accepted: 05 10 2022
entrez: 6 3 2023
pubmed: 7 3 2023
medline: 8 3 2023
Statut: ppublish

Résumé

It has been reported that glycogen in Escherichia coli has two structural states, that is, fragility and stability, which alters dynamically. However, molecular mechanisms behind the structural alterations are not fully understood. In this study, we focused on the potential roles of two important glycogen degradation enzymes, glycogen phosphorylase (glgP) and glycogen debranching enzyme (glgX), in glycogen structural alterations. The fine molecular structure of glycogen particles in Escherichia coli and three mutants (ΔglgP, ΔglgX and ΔglgP/ΔglgX) were examined, which showed that glycogen in E. coli ΔglgP and E. coli ΔglgP/ΔglgX were consistently fragile while being consistently stable in E. coli ΔglgX, indicating the dominant role of GP in glycogen structural stability control. In sum, our study concludes that glycogen phosphorylase is essential in glycogen structural stability, leading to molecular insights into structural assembly of glycogen particles in E. coli.

Identifiants

pubmed: 36876811
pii: S0144-8617(22)01105-5
doi: 10.1016/j.carbpol.2022.120200
pii:
doi:

Substances chimiques

Glycogen 9005-79-2
Glycogen Debranching Enzyme System 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120200

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no competing financial interest.

Auteurs

Fen Li (F)

Laboratory Medicine, The Fifth People's Hospital of Huai'an, Huai'an, Jiangsu Province, China.

Meng-Meng Wang (MM)

Department of Pharmacy, Qingdao Eighth People's Hospital, Qingdao, Shandong Province, China; Department of Pharmaceutical Analysis, School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu Province, China.

Qing-Hua Liu (QH)

State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macao SAR, China.

Zhang-Wen Ma (ZW)

Department of Pharmaceutical Analysis, School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu Province, China.

Jun-Jiao Wang (JJ)

Department of Intelligent Medical Engineering, School of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu Province, China.

Zi-Yi Wang (ZY)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.

Jia-Wei Tang (JW)

Department of Intelligent Medical Engineering, School of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu Province, China.

Jing-Wen Lyu (JW)

Laboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China.

Zuo-Bin Zhu (ZB)

Department of Genetics, School of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, China. Electronic address: zhuzuobin@xzhmu.edu.cn.

Liang Wang (L)

Laboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China. Electronic address: wangliang@gdph.org.cn.

Articles similaires

Arabidopsis Arabidopsis Proteins Osmotic Pressure Cytoplasm RNA, Messenger
Female Biofilms Animals Lactobacillus Mice
Host Specificity Bacteriophages Genomics Algorithms Escherichia coli
Biofilms Horses Animals Escherichia coli Mesenchymal Stem Cells

Classifications MeSH